Concepedia

Henrik Schmidt

HS

Statistics

Publications

66

Citations

13.6K

H-Index

35

Active since

2000

Affiliations

Aarhus University Hospital(Current)

Odense University Hospital

Institut Gustave Roussy

University of Siena

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Henrik Schmidt is an author at Aarhus University Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2000–2024

66

Publications

66

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.3K citations · Full text

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob et al. · New England Journal of Medicine · 2016 · 1.3K citations · Full text

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob et al. · The Lancet Oncology · 2015 · 1.2K citations

, , +8

An immune-active tumor microenvironment favors clinical response to ipilimumab

Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang et al. · Cancer Immunology Immunotherapy · 2011 · 775 citations · Full text

, , +8

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 530 citations · Full text

1–5 of 66